{name}
{subtitle}
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~38 mi. (Graz, Austria, +192 more cities)
facility
Universitätsklinikum Graz
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~38 mi. (Graz, Austria, +176 more cities)
facility
Medizinische Universitat Graz ( Site 2004)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~38 mi. (Graz, Austria, +89 more cities)
facility
Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 1609)
biomarker
ER Positive, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~38 mi. (Graz, Austria, +147 more cities)
facility
Medizinische Universitat Graz ( Site 0569)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~38 mi. (Graz, Austria, +150 more cities)
facility
Landeskrankenhaus - Universitatsklinikum Graz ( Site 1902)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~38 mi. (Graz, Austria, +145 more cities)
facility
Landeskrankenhaus - Universitatsklinikum Graz ( Site 0804)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~38 mi. (Graz, Austria, +165 more cities)
facility
Medizinische Universitaet Graz /ID# 220910
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)
city
~38 mi. (Graz, Austria, +76 more cities)
facility
Medizinische Universität Graz ( Site 0201)
drug
docetaxel, +1 more drug
drug type
chemotherapy, +1 more type